Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder

NCT01133301 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.

NCT NCT01133301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01133301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder
Lead sponsor
Central Institute of Mental Health, Mannheim
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1998
Completion date
October 31, 2001
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder, dissociation